Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NACDS offers platform for CPSIA certification

This article was originally published in The Tan Sheet

Executive Summary

Members of the National Association of Chain Drug Stores can access for free an online platform that allows for exchange of certificates of conformity with the Consumer Product Safety Improvement Act. The trade group and RollStream, a McLean, Va.-based software provider, announced Nov. 17 the launch of the Certificate Exchange Network. The platform allows retailers "to enter one site to obtain certificates for a large portion of the products they sell," an NACDS spokeswoman said in an e-mail. Manufacturers that already set up their own systems can link to certificates through the NACDS network, a RollStream spokeswoman said. Industry stakeholders recommended electronic certificates to comply with CPSIA, which the Consumer Product Safety Commission will enforce for packaging for iron-containing vitamins and other OTCs beginning Feb. 10, 2010 (1"The Tan Sheet" Oct. 12, 2009)

You may also be interested in...

Electronic CPSIA Packaging Certification Offers Key Benefits Over Paper

An electronic certification system will simplify compliance with the Consumer Product Safety Improvements Act of 2008 and likely will satisfy retailers demanding the certificates, experts say

Biogen’s Recipe For Success In Knowledge Management

Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.

Market Intel: Minimally Invasive Procedures Gaining Traction In BPH Treatment Market

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts